70 likes | 206 Views
Is It A Human Carcinogen?. Samuel M. Cohen, M.D., Ph.D. Professor and Chair, Pathology and Microbiology Havlik-Wall Professor of Oncology University of Nebraska Medical Center 983135 Nebraska Medical Center Omaha, NE 68198-3135. Debate at March, 2005 SOT Meeting.
E N D
Is It A Human Carcinogen? Samuel M. Cohen, M.D., Ph.D. Professor and Chair, Pathology and Microbiology Havlik-Wall Professor of Oncology University of Nebraska Medical Center 983135 Nebraska Medical Center Omaha, NE 68198-3135 Debate at March, 2005 SOT Meeting
2 Year Bioassay – Gold Standard • In past 40 years we have identified precursor changes of carcinogenesis.
Present Paradigm: • 4 and 13 week assays 2 year bioassay tumors evaluate dose, metabolism, kinetics, MOA New Approach: • 4 and 13 week assays, DNA reactivity, estrogenicity, immunosuppression precursor changes detailed evaluation of dose, metabolism, kinetics, MOA evaluate relevance to humans.
MOA – Key Events A B C D Cancer Focus on precursor key events! Detailed analysis – dose, metabolism, kinetics, MOA. Is it relevant to humans?
Urinary Bladder DNA Reactivity Yes No Bladder Hyperplasia Bladder Hyperplasia SEM Changes BrdU LI - urothelium No Yes Likely BladderCarcinogen Not Likely a Bladder Carcinogen Possible Bladder Carcinogen Not a Bladder Carcinogen Evaluate Fresh Void Urine Urinary Solids Urinary Composition? Reactive Chemical and/or metabolite